Medications

FDA: Zofran 32-mg dose pulled from market

(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

Diseases, Conditions, Syndromes

Rapid COVID-19 test granted EU approval

Even as coronavirus testing is ramping up across the world, the issue of speed and accuracy in diagnosis still poses a challenge for public health authorities. A research group supported by the EU-funded HG nCoV19 test project ...

page 4 from 10